Cellphire Inc. Secures $70.3 Million Modification: Research and Development of Cryopreserved Platelets

Cellphire Inc., Frederick, Maryland, is awarded a $70,334,798 cost-plus-fixed-fee modification to a previously awarded contract (W81XWH20C0030). This effort is to increase the cost ceiling of the current contract and add an additional 20-month extension to the period of performance to Oct. 31, 2028. The necessity of a contract modification is due to an increase in the number of subjects required to statistically show non-inferiority between cryopreserved and liquid stored platelets. Fiscal 2025 research, development, test and evaluation funding is obligated at the time of award. Place of performance is Fort Detrick, Maryland. The U.S. Army Medical Research Acquisition Activity, Contract Branch Seven, Fort Detrick, Maryland, is the contracting activity